BEIJING: About 90 per cent of Sinovac Biotech employees and their families have taken an experimental coronavirus vaccine developed by the Chinese firm under the country’s emergency use program, its chief executive said on Sunday (Sep 6). The extent of inoculations under the emergency program …
